Samsara BioCapital, LLC Diversified Active

CIK: 0001744967 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 18, 2020

Total Value ($000): $208,709 (100.0% shares, 0.0% debt)

Holdings (19)

— Intercept Pharmaceuticals Inc 24.0%

Value ($000) $50,025 Shares 403,688 Est. Cost $88.27 Unrealized —

— Springworks Therapeutics Inc 12.1%

Value ($000) $25,153 Shares 653,502 Est. Cost $21.68 Unrealized —

— Allakos Inc 11.1%

Value ($000) $23,125 Shares 242,505 Est. Cost $52.27 Unrealized —

— Odonate Therapeutics Inc 8.1%

Value ($000) $16,960 Shares 522,637 Est. Cost $14.81 Unrealized —

— Principia Biopharma Inc 8.1%

Value ($000) $16,806 Shares 306,784 Est. Cost $27.39 Unrealized —

— Sutro BioPharma Inc 5.9%

Value ($000) $12,381 Shares 1,125,579 Est. Cost $9.02 Unrealized —

— Syros Pharmaceuticals Inc 5.4%

Value ($000) $11,255 Shares 1,726,603 Est. Cost $6.82 Unrealized —

— Atreca Inc 4.4%

Value ($000) $9,148 Shares 591,368 Est. Cost $18.84 Unrealized —

— Aravive Inc 3.8%

Value ($000) $7,875 Shares 576,066 Est. Cost $5.87 Unrealized —

— Hookipa Pharma Inc 3.1%

Value ($000) $6,485 Shares 530,245 Est. Cost $6.73 Unrealized —

— Iveric Bio, Inc. 2.9%

Value ($000) $6,006 Shares 700,000 Est. Cost $8.58 Unrealized —

— Millendo Therapeutics Inc 2.3%

Value ($000) $4,820 Shares 715,201 Est. Cost $6.89 Unrealized —

LQDA Liquidia Technologies Inc 2.0%

Value ($000) $4,097 Shares 958,466 Est. Cost $6.60 Unrealized -39.2%

— Bellus Health Inc 1.8%

Value ($000) $3,693 Shares 488,858 Est. Cost $7.55 Unrealized —

— Pieris Pharmaceuticals Inc 1.2%

Value ($000) $2,549 Shares 704,226 Est. Cost $3.62 Unrealized —

UROV Urovant Sciences Ltd 1.2%

Value ($000) $2,443 Shares 157,480 Est. Cost $6.59 Unrealized —

KALV KalVista Pharmaceuticals Inc 1.0%

Value ($000) $2,110 Shares 118,500 Est. Cost $20.10 Unrealized -35.1%

— Sunesis Pharmaceuticals Inc 1.0%

Value ($000) $2,005 Shares 5,938,215 Est. Cost $0.75 Unrealized —

— Catabasis Pharmaceuticals Inc 0.8%

Value ($000) $1,773 Shares 300,000 Est. Cost $4.37 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Intercept Pharmaceuticals Inc	403,688	$50,025	24.0%	$88.27	—	COM	45845P108
—	Springworks Therapeutics Inc	653,502	$25,153	12.1%	$21.68	—	COM	85205L107
—	Allakos Inc	242,505	$23,125	11.1%	$52.27	—	COM	01671P100
—	Odonate Therapeutics Inc	522,637	$16,960	8.1%	$14.81	—	COM	676079106
—	Principia Biopharma Inc	306,784	$16,806	8.1%	$27.39	—	COM	74257L108
—	Sutro BioPharma Inc	1,125,579	$12,381	5.9%	$9.02	—	COM	869367102
—	Syros Pharmaceuticals Inc	1,726,603	$11,255	5.4%	$6.82	—	COM	87184Q107
—	Atreca Inc	591,368	$9,148	4.4%	$18.84	—	COM	04965G109
—	Aravive Inc	576,066	$7,875	3.8%	$5.87	—	COM	03890D108
—	Hookipa Pharma Inc	530,245	$6,485	3.1%	$6.73	—	COM	43906K100
—	Iveric Bio, Inc.	700,000	$6,006	2.9%	$8.58	—	COM	46583P102
—	Millendo Therapeutics Inc	715,201	$4,820	2.3%	$6.89	—	COM	60040X103
LQDA	Liquidia Technologies Inc	958,466	$4,097	2.0%	$6.60	-39.2%	COM	53635D202
—	Bellus Health Inc	488,858	$3,693	1.8%	$7.55	—	COM	07987C204
—	Pieris Pharmaceuticals Inc	704,226	$2,549	1.2%	$3.62	—	COM	720795103
UROV	Urovant Sciences Ltd	157,480	$2,443	1.2%	$6.59	—	COM	G9381B108
KALV	KalVista Pharmaceuticals Inc	118,500	$2,110	1.0%	$20.10	-35.1%	COM	483497103
—	Sunesis Pharmaceuticals Inc	5,938,215	$2,005	1.0%	$0.75	—	COM	867328700
—	Catabasis Pharmaceuticals Inc	300,000	$1,773	0.8%	$4.37	—	COM	14875P206